Greiner Bio-One, a leading technology partner for the diagnostic and pharmaceutical industries, unveiled a new black 96 well cycloolefin microplate at the Society for Laboratory Automation and Screening¹ (SLAS) conference exhibition in Orlando, Florida

Especially developed for high-resolution microscopy, the ultra-low well base of SCREENSTAR enables high magnification microscopy of perimeter wells, even with a minimum working distance.

Greiner Bio-One has expanded its microplate product portfolio with the introduction of a new black 96 well microplate that features a 190 micrometers ultra-clear film bottom. Manufactured entirely of cycloolefin, an innovative material with glass-like optical properties, SCREENSTAR facilitates outstanding image quality of well contents.

The microplate's key advantage over other plates for high-resolution microscopy is the extremely short distance between the well bottom and the microplate skirt (internal well to skirt bottom = 0.7 mm; external well to skirt bottom = 0.51 mm), rendering ease of high magnification microscopy at perimeter wells without complex microscopic adjustments. The circular wells allow microscopic work without disruptive shadow using the smallest possible meniscus lens. The perimeter ditch can be filled with water or medium to reduce edge effect due to evaporation, especially for long incubation periods. A proven Greiner Bio-One cell culture treatment quality ensures reliable, uniform growth.

The 96 well SCREENSTAR plate is available in black with a 190 micrometers clear film bottom, cell culture treated, sterile, with lid, individually packed. The microplate well bottoms are protected by a film that must be removed prior to use.  The identical microscopy plate is additionally available with a glass bottom and will be unveiled shortly.

For more about the new 96 well SCREENSTAR microplate click here

About Greiner Bio-One GmbH

BioScience Division Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory products. The company is a technology partner for universities, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well. With the BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures, as well as microplates for high-throughput screening, allowing industry and research most rapid and efficient drug screening. Additionally Greiner Bio-One develops innovative biochip technologies for genotyping.

Under the management of Georg Heftberger, Rainer Perneker and Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen

(Baden-Württemberg) controls the whole research and development activities in the product ranges Cell Culture, High-Throughput Screening, Biochips and OEM.

Greiner Bio-One GmbH is a division of Greiner Bio-One International AG, based in Kremsmuenster (Austria). Today Greiner Bio-One International AG generates a turnover of 327 million euros. It has over 1,700 employees and operates globally with 20 subsidiaries and numerous distributors in more than 100 countries.

more news from Greiner Bio-One